
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded slow release capsule containing diphenhydramine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing diphenhydramine are listed in capsule, tablet, injection and solution forms.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Diphenhydramine is a first-generation antihistamine that compounding pharmacies prepare by prescription in topical creams and gels, oral suspensions and mouth rinses.
Diphenhydramine is a first-generation H1 antihistamine. It blocks histamine, the chemical the body releases during allergic reactions, and because it crosses into the brain it also causes drowsiness. It has anticholinergic (drying) activity and blocks nerve sodium channels, which gives it mild local anesthetic properties. Manufactured products include over-the-counter oral tablets, capsules and liquids for allergy and cold symptoms, occasional sleeplessness and motion sickness, and a prescription injection that is FDA-approved for allergic reactions to blood products, as an adjunct to epinephrine in anaphylaxis, motion sickness and some cases of parkinsonism when oral dosing is not practical. A prescriber might order compounded diphenhydramine for a strength or dosage form that is not manufactured, a dye-free or sugar-free liquid, or a combination with other ingredients in a topical or oral rinse. Compounded preparations are not FDA-approved and require a prescription.
Diphenhydramine causes drowsiness, dizziness and poor coordination, so do not drive until you know how it affects you; alcohol and other sedatives add to this. It can cause dry mouth, constipation, blurred vision, fast heartbeat and trouble urinating, and children may become excited rather than sleepy. Call your prescriber right away for vision changes or painful or difficult urination. Use caution with glaucoma, an enlarged prostate, asthma, heart disease, high blood pressure or an overactive thyroid. MAO inhibitors intensify its effects; avoid combining it with other strongly anticholinergic drugs. The Beers Criteria advise avoiding it in adults 65 and older. The injection label says it must not be used in premature infants or newborns, as a local anesthetic, or by nursing mothers; LactMed says occasional small doses are unlikely to harm a breastfed infant but larger or prolonged doses can sedate the baby or lower milk supply. Tell your prescriber if you are pregnant. For side effects, talk to your prescriber or pharmacist.
Diphenhydramine is an H1 inverse agonist with antimuscarinic and sodium channel blocking activity; it crosses the blood-brain barrier and suppresses the medullary cough center. Oral bioavailability is about 72% after extensive first-pass metabolism, predominantly by CYP2D6; peak concentration occurs at about 1.5 hours, plasma protein binding is about 98%, volume of distribution is large, and the elimination half-life is roughly 9 hours in adults and 5.4 hours in children, with about 2% excreted unchanged renally. Labeled indications: diphenhydramine hydrochloride injection (Fresenius Kabi and others) for antihistaminic use when oral therapy is impractical, including blood product reactions and anaphylaxis adjunct, motion sickness and parkinsonism; OTC oral products for allergy, cold, sleep and motion sickness. Prescribers have ordered compounded diphenhydramine for oral mucositis rinses, pruritus and local anesthesia (StatPearls), off-label uses. Dosing is per prescriber. Monitor mental alertness, anticholinergic effects, urinary retention in older men, QTc in at-risk patients and, per StatPearls, baseline creatinine in pediatric patients. Parenteral use as a local anesthetic has caused tissue necrosis. Diphenhydramine is not a controlled substance.
Swallow the capsule whole with fluid. Do not crush, chew, divide or open it, and do not dissolve it in liquid, because that can release the full dose at once. Take it at the same times each day as your label directs. Slow release forms are not meant for feeding tubes; ask your pharmacist if you need a different form.
These are nonaqueous capsules, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in a closed container at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth